Trial intelligence / Profile preview

Prophylactic nimodipine and hydroxyethyl starch to improve facial and vestibulocochlear nerve function after acoustic neuroma surgery

2009-012088-32Phase 3Completed

Sponsor
Martin Luther University Halle-Wittenberg
Start
Oct 2009
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised trial of nimodipine in acoustic neuroma (2 arms), sponsored by Martin Luther University Halle-Wittenberg. Primary endpoint: Facial nerve function at 12 months. Started Oct 2009; status: completed.

02

Drugs

nimodipine
03

Conditions

acoustic neuroma

Beyond the preview

Go deeper on 2009-012088-32.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2009-012088-32.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call